Back to Results
First PageMeta Content
Microbiology / HIV / Entry inhibitor / CCR5 / AIDS / Vicriviroc / Microbicides for sexually transmitted diseases / Gp41 / CD4 / HIV/AIDS / Biology / Chemistry


F O C U S O N T R A N S L AT I O N A L I M M URNEOVLO GY IEW
Add to Reading List

Document Date: 2007-03-22 18:29:13

Open Document

File Size: 491,74 KB

Share Result on Facebook

City

Geneva / Padian / Bristol / Rakai / Cleveland / Alexander / Shiboski / Rio de Janeiro / Gardner / /

Company

Cellegy Pharmaceuticals Gilead Sciences Tibotec Pharmaceuticals / Merck & Co. / Tibotec Pharmaceuticals / CCR5 / Baleta / Progenics Pharmaceuticals / Takeda Pharmaceuticals North America / Fvs / Indevus Pharmaceuticals / GlaxoSmithKline / HIV / Cellegy Pharmaceuticals / Gilead Sciences / Polydex Pharmaceuticals / Plough Corporation / Schering / Stephens / NA Cellegy Pharmaceuticals / Gilead Sciences Tibotec Pharmaceuticals / /

Country

Switzerland / South Africa / United States / Uganda / Malawi / Brazil / /

/

Event

FDA Phase / M&A / /

Facility

*Case Western Reserve University / University NA Tested / Weill Medical College of Cornell / University of Vienna Tested / N terminus / /

IndustryTerm

chemical synthesis / experimental systems / co-receptor-binding site / pharmaceutical industry / prevention of HIV / blood products / polyanion binding site / HIV prevention / formulation and delivery tools / pharmaceutical / HIV treatment / HIV therapeutics / biotechnology industry / citrata oil / large scale and on site / administered products / mainstream pharmaceutical industry / mature technology / chemical irritation / /

MedicalCondition

sexually transmitted disease / alloantigen-induced inflammation / epidemic / bacterial vaginosis / mucosal inflammation / local inflammation / sexually transmissible infections / chronic exposure / chemical irritation / factors limiting infection / SHIV infection / primary infection / less irritation / non-obese diabetic SCID / infections / HIV infection / ulcerative infections / epithelial Langerhans cell Direct infection / ulcerative disease / Ulcerative infection / acute HIV infection / rabbit vaginal irritation / AIDS-related diseases / early infection / acute primary HIV infection / study genital irritation / sexually transmitted infections / increased inflammatory responses / AIDS / SCID / irritation / infection / SIV infection / inflammation / infectious disease / acute infection / inflammatory / sexually transmitted diseases / /

MedicalTreatment

salvage therapy / antiretroviral therapies / male circumcision / /

Organization

conformationScripps Research Institute / Laval University / World Health Organization / Department of Structural Biology and Bioinformatics Centre Médical Universitaire / Cornell / Case Western Reserve University / Weill Medical College / United States Agency for International Development / United Nations / University of Vienna Tested / Population Council / Cellegy Pharmaceuticals University of Vienna Tested / UNAIDS / Mintaka Foundation for Medical Research / /

Person

Robin E. Offord / Fuzeon Enfuviritide / F. Hoffmann / Tanox / Carraguard Carrageenan / Oliver Hartley / Michael M. Lederman / /

Position

model / risks / vaginal challenge model / /

Product

Nokia N73 Smartphone / Fuzeon / Viread / T-20 C52L / Phase I / Tested / Phase III / Biofem Phase II / N-9 / Phase I/II / /

ProgrammingLanguage

DC / /

ProvinceOrState

New Jersey / Ohio / South Carolina / Nova Scotia / M. B. / /

Region

sub-Saharan Africa / western Uganda / /

Technology

Bioinformatics / antibodies / biotechnology / mature technology / pdf / /

URL

www.nature.com/reviews/immunol / http /

SocialTag